We are proud to announce the successful completion of the multi-phase strip-out project for GSK Rixensart 16, which took place from November 2022 to January 2023. This project involved the removal of an entire building’s worth of equipment, executed in several phases to ensure efficiency and minimal disruption. It highlights our commitment to delivering cost-effective, sustainable, and high-quality solutions for our clients.
The strip-out process was carried out in multiple phases, allowing for a systematic and efficient approach to dismantling and removing equipment from GSK’s facility. Our team ensured that each phase was executed seamlessly, delivering maximum value to the client.
This project was a testament to the strong partnership between IMT Life Science Processing and GSK. Our expertise in asset management, project execution, and cost optimization played a key role in achieving these outstanding results.
The successful completion of the GSK Rixensart 16 strip-out project reinforces our commitment to providing innovative, cost-effective, and sustainable solutions for our clients. We look forward to continuing our collaboration with GSK and taking on new challenges in the future.
At IMT Life Science Processing, we pride ourselves on delivering value-driven results and exceptional service. Stay tuned for more updates on our upcoming projects and achievements!
For more information about our services or to discuss how we can assist with your next project, feel free to reach out to us.